Precigen (PGEN) Invested Capital (2011 - 2026)

Precigen (PGEN) has 16 years of Invested Capital data on file, last reported at $113.8 million in Q1 2026.

• Invested Capital for Q1 2026 came in at $113.8 million, up 909.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $113.8 million (up 909.06% YoY), and the FY2025 annual result was $114.1 million, up 196.22% from the prior year.
• Invested Capital was little changed at $113.8 million in Q1 2026 per PGEN's latest filing, from $114.1 million in the prior quarter.
• Over five years, Invested Capital peaked at $275.3 million in Q1 2022 and troughed at -$36.8 million in Q2 2025.
• A 5-year average of $123.5 million and a median of $118.5 million in 2023 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2025 and 2026: Invested Capital plunged 185.2% in 2025, then jumped 909.06% in 2026.
• A 5-year view of Invested Capital shows it stood at $169.5 million in 2022, then sank by 30.08% to $118.5 million in 2023, then tumbled by 67.5% to $38.5 million in 2024, then jumped by 196.22% to $114.1 million in 2025, then slipped by 0.29% to $113.8 million in 2026.
• Business Quant data shows PGEN's Invested Capital at $113.8 million in Q1 2026, $114.1 million in Q4 2025, and $134.8 million in Q3 2025.